Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
602
datasets available to search
ShareScore release 0.9.0
Dataset results
602 results for “natural killer cell”
Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma
ClinicalTrials.gov study NCT02280525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis
ClinicalTrials.gov study NCT06040918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
ClinicalTrials.gov study NCT00909558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06367673. IPD Sharing: NO. Countries: 1. Publications: 0.
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
ClinicalTrials.gov study NCT04489420. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
ClinicalTrials.gov study NCT06158828. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
ClinicalTrials.gov study NCT00918658. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02316964. IPD Sharing: NO. Countries: 1. Publications: 0.
High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03007875. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML
ClinicalTrials.gov study NCT05334693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Neg
ClinicalTrials.gov study NCT06026657. IPD Sharing: NO. Countries: 1. Publications: 0.
Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease
ClinicalTrials.gov study NCT04209712. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated N
ClinicalTrials.gov study NCT02639832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy in r/r AML
ClinicalTrials.gov study NCT05665114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer
ClinicalTrials.gov study NCT04557306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
ClinicalTrials.gov study NCT05020678. IPD Sharing: NO. Countries: 2. Publications: 0.
Age-matched Reference Values for Circulating Natural Killer T-like Cells
ClinicalTrials.gov study NCT06450743. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)
ClinicalTrials.gov study NCT02118415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer (NK) Cell Therapy for B-Cell Malignancies
ClinicalTrials.gov study NCT05379647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous Natural Killer T Cells Infusion for the Treatment of Cancer
ClinicalTrials.gov study NCT01801852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.